Cartesian Therapeutics
RNAC
RNAC
53 hedge funds and large institutions have $222M invested in Cartesian Therapeutics in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 24 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.28% less ownership
Funds ownership: 2.12% → 1.84% (-0.28%)
5% less capital invested
Capital invested by funds: $235M → $222M (-$12.3M)
Holders
53
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$6.66M | |
| 2 | +$5.46M | |
| 3 | +$1.73M | |
| 4 |
BlackRock
New York
|
+$1.43M |
| 5 |
Two Sigma Investments
New York
|
+$951K |
Top Sellers
| 1 | -$5.41M | |
| 2 | -$3.71M | |
| 3 | -$2.38M | |
| 4 |
DM
Deerfield Management
New York
|
-$1.98M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$650K |